Reversal of fortune: estrogen receptor-β in endometriosis

J Mol Endocrinol. 2016 Aug;57(2):F23-7. doi: 10.1530/JME-16-0080. Epub 2016 Jun 7.

Abstract

Enhanced inflammation and reduced apoptosis sustain the growth of endometriotic lesions. Alterations in the expression of estrogen receptor-alpha (ERα) and estrogen receptor-beta (ERβ) accompany the conversion of resident endometrial cells within the normal uterine environment to ectopic lesions located in extrauterine sites. Recent studies highlighted in this focused review linked ERβ to dysregulation of apoptotic and inflammatory networks involving novel interacting partners in endometriosis. The elucidation of these nongenomic actions of ERβ using human cells and mouse models is an important step in understanding key regulatory pathways that are disrupted leading to disease establishment and progression.

Keywords: apoptosome; endometriosis; estrogen receptor-beta; inflammation; non-genomic.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Endometriosis / genetics
  • Endometriosis / metabolism*
  • Endometrium / metabolism
  • Endometrium / pathology
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor alpha / metabolism
  • Estrogen Receptor beta / genetics
  • Estrogen Receptor beta / metabolism*
  • Female
  • Gene Expression Regulation
  • Humans
  • Inflammasomes / metabolism
  • Inflammation / genetics
  • Inflammation / metabolism
  • Inflammation / pathology
  • Models, Biological
  • Protein Binding
  • Signal Transduction

Substances

  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Inflammasomes